The Feasibility of Using Bayh-Dole March-In Rights to Lower Drug Prices: An Update

In December 2023, the Biden-Harris Administration released a proposed framework for exercising government “march-in” rights on high-priced taxpayer-funded drugs. While both proponents and critics of the new rules view them … Continue reading The Feasibility of Using Bayh-Dole March-In Rights to Lower Drug Prices: An Update